相似文献
1
The impact of bacterial genomics on antibacterial discovery.
Adv Exp Med Biol. 1998;456:183-95. doi: 10.1007/978-1-4615-4897-3_10.
2
Functional genomics in antibacterial drug discovery.
Drug Discov Today. 2005 Jul 1;10(13):927-35. doi: 10.1016/S1359-6446(05)03474-4.
3
The new antibiotics.
Nat Biotechnol. 1999 Dec;17(12):1165-9. doi: 10.1038/70705.
4
Microbial fitness and genome dynamics.
Trends Microbiol. 2001 Aug;9(8):356-8. doi: 10.1016/s0966-842x(01)02099-6.
5
Bacterial genome sequencing and drug discovery.
Curr Opin Biotechnol. 1998 Dec;9(6):637-42. doi: 10.1016/s0958-1669(98)80143-2.
6
Whither antibacterial drug discovery?
Drug Discov Today. 2008 Apr;13(7-8):279-80. doi: 10.1016/j.drudis.2008.03.010.
7
Use of genomics to select antibacterial targets.
Biochem Pharmacol. 2006 Mar 30;71(7):1066-72. doi: 10.1016/j.bcp.2005.12.004. Epub 2006 Jan 18.
8
When will the genomics investment pay off for antibacterial discovery?
Biochem Pharmacol. 2006 Mar 30;71(7):1096-102. doi: 10.1016/j.bcp.2005.11.025. Epub 2006 Jan 4.
9
Impact of molecular biology on antibiotic susceptibility: testing and therapy.
Am J Med. 1995 Dec 29;99(6A):21S-25S. doi: 10.1016/s0002-9343(99)80281-2.
10
Antibacterial drug discovery--then, now and the genomics future.
Biochem Pharmacol. 2006 Mar 30;71(7):901-9. doi: 10.1016/j.bcp.2005.11.023. Epub 2006 Feb 21.
引用本文的文献
1
Comparative genomic assessment of novel broad-spectrum targets for antibacterial drugs.
Comp Funct Genomics. 2004;5(4):304-27. doi: 10.1002/cfg.411.
Zotero 插件